Intel's $15 Billion Stock Offering: What to Know

Intel is tapping the equity market to pay for its comeback. On August 10, 2026, the company announced a proposed public offering of $15 billion in common stock, one of the largest equity raises in its history and, by the company’s framing, a bet that AI demand will keep its foundry and product roadmaps fully booked. Intel shares fell about 4.5% in pre-market trading on the news — the standard reflex when a company sells a large slug of new shares.

The raise lands weeks after Intel posted a stronger-than-expected quarter, and it signals that management intends to press its advantage while the stock is up and demand signals are pointing the right way.

The terms

Intel said it will sell $15 billion of common stock through a public offering, with underwriters granted a customary 30-day option to purchase up to an additional $2.25 billion of shares — a “greenshoe” that could push gross proceeds toward $17.25 billion if exercised in full. JPMorgan, Goldman Sachs, Morgan Stanley, and Citigroup are acting as joint book-running managers.

The company framed the use of proceeds broadly: pursuing “growth opportunities in physical AI, purpose-built silicon, advanced packaging, and external wafers.” In plain terms, that is money for capacity — the fabs, advanced packaging lines, and tooling Intel needs to manufacture both its own chips and those it makes for outside customers through its foundry business.

Selling common stock is the most dilutive way a company can raise money: unlike debt, new shares permanently divide future earnings among a larger base. For the mechanics of why a raise like this pressures the share price on announcement, see our explainers on secondary offerings and equity dilution. The tradeoff is that equity carries no interest payments and no repayment date — attractive for a capital program measured in years, and a notable choice given how much of the industry’s AI buildout has been financed with debt.

The backdrop: a quarter that gave management cover

The timing is not accidental. Intel’s second-quarter results showed revenue of $16.1 billion, up 25% year over year, and the stock has rallied on signs the turnaround is taking hold. Companies raise equity when their shares are strong and the story is good; both conditions held this week.

Management also told investors that customers are signaling strong demand growth driven by AI computing investment, and it raised its 2026 capital-spending forecast from $18 billion to about $20 billion, with spending expected to increase “meaningfully” again in 2027. A rising capex line and a $15 billion raise are two halves of the same message: Intel intends to spend aggressively to build capacity, and it wants the balance sheet to support that without leaning entirely on borrowing.

That capacity story spans several fronts Intel has been pushing this year — its €5 billion Ireland fab expansion, its move to high-volume High-NA EUV logic production, and a foundry business trying to win external customers against TSMC. Each of those is capital-hungry, and leading-edge lithography in particular does not come cheap: a single High-NA EUV tool runs into the hundreds of millions of dollars.

Why the stock dipped anyway

A 4.5% pre-market drop on a growth-funding raise is not a verdict on Intel’s strategy; it is arithmetic and signaling. Two forces are at work.

First, dilution. A $15 billion raise against Intel’s market value is a meaningful share-count increase, and existing holders instantly own a slightly smaller slice of the company. Markets price that in immediately.

Second, signaling. When a company sells stock, some investors read it as management believing the shares are fully valued — you sell equity when it is expensive, not cheap. Intel’s counter is that the proceeds fund revenue-generating capacity, which, if demand holds, grows the earnings the larger share base divides. Whether the raise is accretive or dilutive in the long run depends entirely on the returns Intel earns on the capacity it builds.

What it means

Intel is doing what a capital-intensive manufacturer does when its stock is up and its order book looks strong: raising money to build, while the raising is cheap. The move reads as confidence — you do not commit to a $15 billion equity raise and a $20 billion capex year unless you believe the demand is there to fill the capacity.

Who wins if it works: Intel’s foundry ambitions, which need cash and credibility to court external customers away from TSMC; equipment suppliers like ASML, whose EUV and High-NA tools are exactly what this capital buys; and long-term shareholders, if the new capacity earns a return above Intel’s cost of capital.

Who bears the risk: existing shareholders, who absorb the dilution now against benefits that arrive later — and only if execution holds. Intel’s turnaround is real but not finished, and a raise this size raises the stakes on delivering the manufacturing milestones behind it.

What to watch next: the final share price and size once the offering prices, and whether underwriters exercise the $2.25 billion option — a sign of demand. Then the harder test: foundry customer wins, yield ramps on leading-edge nodes, and whether the AI-demand signals management is citing translate into booked capacity. Intel has the money to build. The market has just told it, in a 4.5% dip, that the money is the easy part.